Hangzhou Sumgen Biotech Co., Ltd.

This is the first human study testing a new cancer drug called SG2918. It aims to find a safe dose and check for early signs that it might help control advanced cancers. The study involves 17 patients whose cancers have stopped responding to standard treatments or who have no oth…

This is the first study in people for a new potential lupus treatment called SG301. It aims to first check the safety of a single dose in healthy volunteers, and then test multiple doses in people with mild-to-moderate lupus. The main goal is to see how safe the drug is and how t…